These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9044027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
    Giacometti A, Cirioni O, Scalise G.
    J Antimicrob Chemother; 1996 Sep; 38(3):399-408. PubMed ID: 8889715
    [Abstract] [Full Text] [Related]

  • 3. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M, Chau F, Derouin F, Girard PM.
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In-vitro activity of topoisomerase inhibitors against Pneumocystis carinii.
    Cirioni O, Giacometti A, Quarta M, Scalise G.
    J Antimicrob Chemother; 1997 Oct; 40(4):583-6. PubMed ID: 9372430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM, Murphy RL, Yurik TM, Luskin-Hawk R, Cheung TW, Balfour HH, Eng R, Hooton TM, Kerkering TM, Schutz M, van der Horst C, Hafner R.
    N Engl J Med; 1998 Dec 24; 339(26):1889-95. PubMed ID: 9862944
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
    Cirioni O, Giacometti A, Barchiesi F, Fortuna M, Scalise G.
    J Antimicrob Chemother; 1999 Nov 24; 44(5):653-9. PubMed ID: 10552982
    [Abstract] [Full Text] [Related]

  • 12. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
    Brun-Pascaud M, Chau F, Simonpoli AM, Girard PM, Derouin F, Pocidalo JJ.
    J Infect Dis; 1994 Sep 24; 170(3):653-8. PubMed ID: 8077724
    [Abstract] [Full Text] [Related]

  • 13. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L, Borio L, Masur H, Kovacs JA.
    J Infect Dis; 1999 Dec 24; 180(6):1969-78. PubMed ID: 10558954
    [Abstract] [Full Text] [Related]

  • 14. Effects of dual combinations of antifolates with atovaquone or dapsone on nucleotide levels in Plasmodium falciparum.
    Yeo AE, Seymour KK, Rieckmann KH, Christopherson RI.
    Biochem Pharmacol; 1997 Apr 04; 53(7):943-50. PubMed ID: 9174107
    [Abstract] [Full Text] [Related]

  • 15. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT, Killmar JT, Oz HS.
    J Infect Dis; 1994 Oct 04; 170(4):906-11. PubMed ID: 7930735
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and characterization of a rapid screening assay for identifying antipneumocystis agents.
    Martinez A, Kovacs JA.
    Antimicrob Agents Chemother; 1993 Aug 04; 37(8):1674-8. PubMed ID: 8215282
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluations.
    Piper JR, Johnson CA, Krauth CA, Carter RL, Hosmer CA, Queener SF, Borotz SE, Pfefferkorn ER.
    J Med Chem; 1996 Mar 15; 39(6):1271-80. PubMed ID: 8632434
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A, Papoulis AT, Forsch RA, Queener SF.
    J Med Chem; 1999 Mar 25; 42(6):1007-17. PubMed ID: 10090784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.